Memorandum report : ensuring that Medicare Part D reimbursement is limited to drugs provided for medically accepted indications.
(eBook)
Description
Also in this Series
More Details
Notes
Citations
United States. Department of Health and Human Services. Office of Inspector General. (2011). Memorandum report: ensuring that Medicare Part D reimbursement is limited to drugs provided for medically accepted indications . Department of Health and Human Services, Office of Inspector General.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. 2011. Memorandum Report: Ensuring That Medicare Part D Reimbursement Is Limited to Drugs Provided for Medically Accepted Indications. Department of Health and Human Services, Office of Inspector General.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. Memorandum Report: Ensuring That Medicare Part D Reimbursement Is Limited to Drugs Provided for Medically Accepted Indications Department of Health and Human Services, Office of Inspector General, 2011.
MLA Citation, 9th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. Memorandum Report: Ensuring That Medicare Part D Reimbursement Is Limited to Drugs Provided for Medically Accepted Indications Department of Health and Human Services, Office of Inspector General, 2011.
Staff View
Grouping Information
| Grouped Work ID | 8d6973a6-eff6-2935-053e-be28d9388c0a-eng |
|---|---|
| Full title | memorandum report ensuring that medicare part d reimbursement is limited to drugs provided for medically accepted indications |
| Author | united states department of health and human servi |
| Grouping Category | book |
| Last Update | 2023-05-05 15:45:20PM |
| Last Indexed | 2024-07-07 00:16:09AM |
Book Cover Information
| Image Source | default |
|---|---|
| First Loaded | Sep 12, 2022 |
| Last Used | Feb 17, 2024 |
Marc Record
| First Detected | Nov 04, 2016 12:00:00 AM |
|---|---|
| Last File Modification Time | May 05, 2023 03:52:03 PM |
MARC Record
| LEADER | 01714cam a2200409 i 4500 | ||
|---|---|---|---|
| 001 | ocn962069481 | ||
| 003 | OCoLC | ||
| 005 | 20161104102913.0 | ||
| 006 | m o d f | ||
| 007 | cr m|||||||||| | ||
| 008 | 161104s2011 dcu ob f000 0 eng c | ||
| 040 | |a GPO|b eng|e rda|e pn|c GPO|d GPO|d MvI | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 074 | |a 0445-B-07 (online) | ||
| 086 | 0 | |a HE 1.75:OEI-07-08-00152 | |
| 088 | |a OEI-07-08-00152 | ||
| 099 | |a HE 1.75:OEI-07-08-00152 | ||
| 110 | 1 | |a United States.|b Department of Health and Human Services.|b Office of Inspector General,|e author. | |
| 245 | 1 | 0 | |a Memorandum report :|b ensuring that Medicare Part D reimbursement is limited to drugs provided for medically accepted indications. |
| 246 | 3 | 0 | |a Ensuring that Medicare Part D reimbursement is limited to drugs provided medically accepted indications |
| 246 | 1 | |i Running title:|a Medically accepted indications for Part D drugs | |
| 264 | 1 | |a Washington, D.C. :|b Department of Health and Human Services, Office of Inspector General,|c 2011. | |
| 300 | |a 1 online resource (9 pages) | ||
| 336 | |a text|2 rdacontent | ||
| 337 | |a computer|2 rdamedia | ||
| 338 | |a online resource|2 rdacarrier | ||
| 500 | |a "Nov[ember] 14 2011." | ||
| 500 | |a "OEI-07-08-00152." | ||
| 500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | |a Description based on online resource; title from PDF title page (HHS, viewed Nov. 3, 2016). | ||
| 650 | 0 | |a Medicare. | |
| 650 | 0 | |a Pharmaceutical services insurance|z United States. | |
| 650 | 0 | |a Drugs|x Prescribing|z United States. | |
| 856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/gpo74122 |
| 949 | |a HE 1.75:OEI-07-08-00152|t x | ||